Advertisement

Cancer genomics tests developed by Cambridge-based Foundation Medicine Inc. are part of a collaboration with biopharmaceuticals firm Celgene Corp., which will apply the tests to its own clinical drug trials.

The collaboration is the second of its kind for Foundation Medicine, which also teamed up with Novartis in January.

SOURCE

Advertisement
Advertisement